Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Aseptic Loosening in Total Hip Arthroplasty

Back to Topics
Contents
0%

Aseptic Loosening in Total Hip Arthroplasty

Comprehensive guide to aseptic loosening after THA - particle disease, osteolysis, Gruen zones, DeLee/Charnley classification, differentiating from infection, and revision planning for orthopaedic exam

complete
Updated: 2024-12-17
High Yield Overview

ASEPTIC LOOSENING IN THA - PARTICLE DISEASE

Wear Debris → Osteolysis → Implant Migration | Rule Out Infection | Paprosky Classification

1%/yrAnnual loosening rate (modern)
2mmLucent line thickness threshold
5mmMigration threshold (2 years)
10-15yrPeak presentation (older implants)

GRUEN ZONES (FEMORAL)

Zone 1
PatternProximal medial (calcar)
TreatmentKey for subsidence
Zone 7
PatternProximal lateral
TreatmentCommon stress shielding
Zones 2-6
PatternMid and distal stem
TreatmentCircumferential loosening

Critical Must-Knows

  • Aseptic loosening = implant failure due to particle-induced osteolysis, NOT infection
  • Wear debris (polyethylene, metal, cement) triggers macrophage activation
  • Gruen zones (1-7) for femur, DeLee/Charnley (I-III) for acetabulum
  • Rule out infection with ESR, CRP, aspiration before labeling as aseptic
  • Paprosky classification guides bone loss management in revision surgery

Examiner's Pearls

  • "
    Aseptic loosening is a biologic process - particle disease
  • "
    Progressive radiolucent lines, migration, subsidence on serial X-rays
  • "
    Must exclude infection - aspirate if any doubt
  • "
    Revision complexity depends on bone loss (Paprosky)

Critical Aseptic Loosening Exam Points

Particle Disease Pathway

Wear debris from bearing surfaces (PE most common) or cement triggers macrophage activation → cytokine release (TNF-α, IL-1, IL-6) → osteoclast recruitment → bone resorption → osteolysis → loosening. This is a biologic, not mechanical, process.

Infection Exclusion Critical

Never assume aseptic without workup. Check ESR, CRP (elevated in infection), hip aspiration (cell count, culture), and consider alpha-defensin or synoviasure. Infection has different management (2-stage vs 1-stage revision).

Radiographic Zones

Gruen zones 1-7 (femoral stem): Zone 1 (calcar resorption/subsidence), Zone 7 (stress shielding). DeLee/Charnley I-III (acetabular): Zone I superior, Zone II medial, Zone III inferior. Progressive lucent lines indicate loosening.

Migration vs. Subsidence

Migration = lateral shift, rotation, or tilt. Subsidence = distal vertical settling. More than 5mm migration in 2 years indicates loosening. Early settling under 2mm may be stable in uncemented stems.

Quick Decision Guide - Aseptic vs Septic Loosening

FeatureAseptic LooseningSeptic Loosening
OnsetGradual (years), progressive painAcute or subacute, persistent pain
ESR/CRPNormal or mildly elevatedElevated (CRP more than 10, ESR more than 30)
Aspiration WCCLess than 3000 cells/μLMore than 3000 cells/μL (PMN more than 80%)
RadiologyProgressive lucent lines, focal osteolysisRapid bone loss, periosteal reaction
TreatmentSingle-stage revisionTwo-stage revision (usually)
Mnemonic

PARTICLE - Mechanism of Aseptic Loosening

P
Polyethylene wear debris
Most common source of particles
A
Activation of macrophages
Phagocytosis of particles
R
Release of cytokines
TNF-α, IL-1, IL-6, RANKL
T
T-cell involvement
Adaptive immune response
I
Inflammation (chronic)
Periprosthetic membrane formation
C
Cytokine-driven osteoclasts
RANKL activates osteoclasts
L
Lysis of bone (osteolysis)
Bone resorption around implant
E
Eventually loosens implant
Loss of fixation, migration

Memory Hook:PARTICLE describes the cascade from wear debris to implant loosening - it's a biologic process

Mnemonic

GRUEN - Femoral Stem Zones (1-7)

G
Greater trochanter region (Zone 1)
Proximal medial, calcar region
R
Region just below (Zone 2)
Medial mid-stem
U
Under the stem tip (Zone 4)
Distal tip region
E
East side proximal (Zone 7)
Proximal lateral
N
Next zones lateral (5, 6)
Lateral mid and distal

Memory Hook:GRUEN zones: 1 and 7 are proximal (medial and lateral), 2-6 spiral down medial then lateral

Mnemonic

DeLee - Acetabular Zones (I-III)

D
Dome (Zone I)
Superior weight-bearing region
e
medial (Zone II)
Central medial region
L
Lower (Zone III)
Inferior/ischial region
e
each zone important
Lucency location matters
e
evaluate all three
Check all zones systematically

Memory Hook:DeLee zones: I (superior dome), II (medial), III (inferior) - think clockwise from top

Mnemonic

ASPIRATION - When to Aspirate Hip

A
Any elevated inflammatory markers
ESR more than 30, CRP more than 10
S
Systemic symptoms present
Fever, malaise, weight loss
P
Pain out of proportion
Worse than expected for aseptic
I
Implant failing rapidly
Rapid bone loss on X-ray
R
Revision being planned
Always rule out before revision
A
Acute onset symptoms
Not gradual deterioration
T
Temperature elevation
Persistent low-grade fever
I
Infection history
Previous wound issues
O
Obvious clinical suspicion
Sinus, drainage, warmth
N
Never assume aseptic
When in doubt, aspirate

Memory Hook:ASPIRATION - When to aspirate: essentially, when ANY suspicion of infection exists

Overview and Epidemiology

Aseptic loosening is the most common indication for revision total hip arthroplasty in the late postoperative period (beyond 5 years). It represents failure of implant fixation due to particle-induced osteolysis rather than infection.

Definition:

  • Loss of mechanical fixation between implant and bone
  • Due to biologic reaction to wear debris (particle disease)
  • Progressive bone resorption (osteolysis) around implant
  • Results in pain, migration, and eventual mechanical failure

Epidemiology:

  • Historical rates: 10-20% at 10 years (older implants)
  • Modern rates: 1-2% per year after first 2 years (improved bearings)
  • Most common between 10-15 years post-primary THA
  • Higher rates with older polyethylene (non-cross-linked)

Modern Improvements

Highly cross-linked polyethylene (HXLPE) has dramatically reduced wear rates from 0.1-0.2mm/year (conventional PE) to under 0.05mm/year. This translates to significantly lower aseptic loosening rates in modern implants. Australian registry data (AOANJRR) confirms this trend.

Risk factors for aseptic loosening:

  • Young, active patients - higher wear rates
  • Obesity - increased joint forces
  • Poor implant positioning - edge loading, impingement
  • Conventional polyethylene - higher wear
  • Thin cement mantles - cement fracture
  • Undersized components - inadequate fixation
  • Osteolysis-prone patients - genetic factors (cytokine polymorphisms)

Pathophysiology - Particle Disease

The particle disease cascade:

Aseptic loosening is fundamentally a biologic process driven by wear particles, not a purely mechanical phenomenon.

Step 1: Particle Generation

  • Polyethylene wear (most common source)
  • Metal-on-metal wear (cobalt/chromium particles)
  • Ceramic particles (if liner fracture)
  • Cement particles (PMMA debris)
  • Corrosion products (at modular junctions)

Step 2: Particle Distribution

  • Particles migrate along effective joint space
  • Enter periprosthetic tissues via joint fluid pumping
  • Size matters: 0.1-10 micron particles most biologically active
  • Smaller particles more phagocytosable, larger particles accumulate

Step 3: Macrophage Activation

  • Macrophages phagocytose wear particles
  • Frustrated phagocytosis - cannot digest polyethylene
  • Macrophage activation and cytokine release
  • Key cytokines: TNF-α, IL-1β, IL-6, RANKL

Step 4: Osteoclast Recruitment

  • RANKL binds to RANK on osteoclast precursors
  • OPG (osteoprotegerin) normally inhibits RANKL
  • Imbalance: RANKL/OPG ratio increased
  • Osteoclast activation and bone resorption

Step 5: Osteolysis and Membrane Formation

  • Periprosthetic membrane forms (granulation tissue)
  • Contains macrophages, giant cells, particles
  • Progressive bone resorption creates cystic lesions
  • Membrane extends along implant-bone interface

Step 6: Mechanical Loosening

  • Loss of bone support
  • Micromotion increases
  • Further particle generation (vicious cycle)
  • Implant migration or subsidence

Vicious Cycle

Loosening creates more micromotion → generates more particles → drives more osteolysis → creates more loosening. This is why early detection and intervention are important - the process accelerates once established.

Genetic factors:

  • Polymorphisms in cytokine genes (TNF-α, IL-1)
  • Some patients are high responders to particles
  • Explains variability in osteolysis rates with similar wear

Classification Systems and Radiographic Assessment

Gruen Zones (Femoral Component)

The femur is divided into 7 zones around the stem on AP radiograph.

Proximal regions:

  • Zone 1: Proximal medial (calcar region)
  • Zone 7: Proximal lateral (greater trochanter region)

Mid-stem regions:

  • Zone 2: Medial mid-stem (above Zone 3)
  • Zone 6: Lateral mid-stem (above Zone 5)

Distal regions:

  • Zone 3: Medial distal
  • Zone 5: Lateral distal
  • Zone 4: Tip of stem (below stem tip)

Clinical significance:

  • Zone 1 lucency: Calcar resorption, subsidence risk
  • Zone 7 lucency: Stress shielding (common, may be stable)
  • Circumferential lucency (all zones): Definitely loose
  • Progressive lucency (increasing on serial films): Loosening
  • Lucency more than 2mm: Concerning for loosening

Zone 7 Stress Shielding

Stress shielding in Zone 7 (proximal lateral) is common with stiff stems and may be stable if non-progressive and stem otherwise well-fixed distally. This differs from true loosening which is progressive and often circumferential.

DeLee and Charnley Zones (Acetabular Component)

The acetabulum is divided into 3 zones on AP radiograph.

Zone I (Superior):

  • Superior dome, weight-bearing region
  • Most critical for load transfer
  • Lucency here concerning for loosening

Zone II (Medial):

  • Central medial region (medial wall)
  • Lucency may indicate medial migration

Zone III (Inferior):

  • Inferior region (ischium)
  • Less common site for initial loosening

Interpretation:

  • Zone I lucency: High concern, weight-bearing area
  • Complete lucency (all 3 zones): Definitely loose
  • Progressive lucency: Loosening in process
  • Migration: Superior or medial shift of cup

Additional acetabular signs:

  • Cup tilt (anteversion/retroversion changes)
  • Superior migration (measured from Köhler's line)
  • Rotation around screws (if present)

This classification helps systematically evaluate acetabular fixation and guide revision planning.

Radiographic Criteria for Loosening

Definite loosening (any one of):

  • Migration (change in position more than 5mm in 2 years)
  • Subsidence (more than 5mm distal settling)
  • Component fracture
  • Cement fracture
  • Complete radiolucent line (circumferential, more than 2mm)

Probable loosening:

  • Progressive radiolucent lines (expanding over time)
  • Expanding osteolysis (growing bone defects)
  • Lucency more than 50% of interface (not circumferential)
  • Lucency more than 2mm thick anywhere

Possibly loose (monitor):

  • Stable thin lucent lines (under 2mm, non-progressive)
  • Focal osteolysis (not expanding)
  • Early subsidence (under 2mm in first year, then stable)

Serial radiographs critical:

  • Compare to immediate postoperative films
  • Annual X-rays to detect progression
  • Measure migration/subsidence quantitatively
  • Document zone-by-zone lucency

Serial Films Essential

Single X-ray cannot diagnose loosening unless gross migration or fracture present. Serial films showing progression of lucent lines or increasing migration are the hallmark of aseptic loosening. Always request comparison films.

Paprosky Classification (Bone Loss)

Used in revision planning to characterize severity of bone loss.

Acetabular (Paprosky):

  • Type I: Intact rim, minimal bone loss (under 25%)
  • Type IIA: Intact rim, superior/medial bone loss (25-50%)
  • Type IIB: Intact rim, superior-lateral migration (under 3cm)
  • Type IIC: Medial wall deficient
  • Type IIIA: Superior migration (more than 3cm), intact Köhler's line
  • Type IIIB: Superior migration, ischial/teardrop destruction

Femoral (Paprosky):

  • Type I: Minimal metaphyseal bone loss, intact diaphysis
  • Type II: Extensive metaphyseal loss, intact diaphysis (more than 4cm)
  • Type IIIA: Metaphyseal loss, diaphysis supportive (more than 4cm)
  • Type IIIB: Extensive metaphyseal and diaphyseal damage
  • Type IV: Extensive diaphyseal loss, non-supportive isthmus

Revision strategy:

  • Type I-II: Standard revision components
  • Type IIA-IIB: Jumbo cups, cluster holes
  • Type IIIA: High hip center, augments
  • Type IIIB: Reconstruction cage, cup-cage construct
  • Type IV femur: Extensively coated stems, allografts, tumor prosthesis

Understanding bone loss classification guides implant selection and surgical planning in revision surgery.

Clinical Presentation and Assessment

History:

  • Onset: Gradual, progressive (years not weeks)
  • Pain: Groin pain (acetabular) or thigh pain (femoral)
  • Start-up pain: Worse after rest, improves with walking
  • Activity limitation: Progressive difficulty with activities
  • Previous function: Often initially well-functioning THA
  • Time since surgery: Typically more than 5-10 years

Symptoms suggesting aseptic (not septic):

  • Gradual onset over months to years
  • No systemic symptoms (no fever, malaise)
  • Pain improving with activity (mechanical)
  • No night sweats or constitutional symptoms

Symptoms raising suspicion for infection:

  • Acute or subacute onset
  • Persistent pain despite rest
  • Systemic symptoms (fever, malaise)
  • Night pain, rest pain
  • History of wound problems

Physical examination:

Physical Examination Findings

FindingSignificanceInterpretation
Antalgic gaitPain with weight-bearingMechanical pain from loosening
Groin pain on axial loadAcetabular component looseningPositive impingement test
Thigh pain on axial loadFemoral component looseningStart-up pain typical
Leg length discrepancyComponent migrationMeasure and compare to prior
Normal wound, no warmthSuggests asepticInfection would show inflammation
Erythema, warmth, sinusSuggests septicRequires infection workup

Range of motion:

  • Usually preserved unless severe migration
  • Pain at end range if impingement
  • Stiffness suggests other pathology (infection, heterotopic ossification)

Neurovascular examination:

  • Document distal pulses, sensation
  • Sciatic nerve (prior posterior approach)
  • Femoral nerve (prior anterior approach)

Investigations and Differential Diagnosis

Radiographic workup:

Standard X-rays (AP pelvis, AP hip, lateral hip):

  • Compare to prior films (serial assessment)
  • Evaluate Gruen zones (femur) and DeLee/Charnley zones (acetabulum)
  • Measure lucent lines (width and extent)
  • Assess for migration (quantify displacement)
  • Look for osteolysis (focal bone loss)
  • Evaluate cement mantle (if cemented)

CT scan (if planning revision):

  • Better assessment of bone loss (Paprosky classification)
  • Identify osteolysis not visible on X-ray
  • Evaluate pelvic discontinuity
  • Plan reconstruction strategy
  • 3D reconstruction for templating

Laboratory investigations:

Laboratory Investigations - Infection Screening

TestAseptic LooseningInfectionAction
ESRNormal or mildly elevated (under 30)Elevated (more than 30)First-line screening
CRPNormal (under 10 mg/L)Elevated (more than 10 mg/L)More specific than ESR
WBCNormalMay be elevatedLess specific for PJI
IL-6Normal or mildly elevatedElevatedResearch tool mostly

Hip aspiration (when to perform):

Indications for aspiration:

  • Any elevated inflammatory markers (ESR more than 30, CRP more than 10)
  • Clinical suspicion of infection
  • All revisions (rule out infection before any revision)
  • Atypical presentation
  • Rapid bone loss

Aspiration technique:

  • Fluoroscopic or ultrasound guidance
  • Lateral approach (avoid contamination)
  • Send for: cell count with differential, culture (hold 14 days), alpha-defensin
  • Stop antibiotics 2 weeks before aspiration

Aspiration interpretation:

Synovial Fluid Analysis

ParameterAsepticInfectedThreshold
WBC countLess than 3000 cells/μLMore than 3000 cells/μL3000 cells/μL
PMN percentageLess than 80%More than 80%80% PMNs
Alpha-defensinNegativePositiveHigh specificity
CultureNegativePositiveGold standard but 7% false negative

MSIS Criteria

Major criteria for PJI (any one = infected):

  1. Sinus tract communicating with prosthesis
  2. Two positive cultures of same organism

Minor criteria (need threshold score):

  • Elevated ESR (more than 30) or CRP (more than 10)
  • Elevated synovial WBC (more than 3000) or PMN (more than 80%)
  • Positive alpha-defensin
  • Positive histology (more than 5 PMNs per high-power field)

If major criteria absent, use scoring system with minor criteria. Always rule out infection before labeling as aseptic.

Additional investigations:

Nuclear medicine (if diagnosis uncertain):

  • Bone scan (Tc-99m): Sensitive but not specific
  • Labeled WBC scan (In-111 or Tc-99m): More specific for infection
  • FDG-PET: High sensitivity for infection but expensive

Other tests:

  • D-dimer: Elevated in infection (but not specific)
  • Synoviasure: Newer biomarker panel
  • PCR for organisms: If culture-negative but high suspicion

Management Algorithm

📊 Management Algorithm
tha aseptic loosening management algorithm
Click to expand
Management algorithm for tha aseptic looseningCredit: OrthoVellum

Step 1: Confirm diagnosis of loosening

  • Serial radiographs showing progression
  • Definite radiographic criteria (migration, lucency)
  • Exclude other causes of pain (referred, spine)

Step 2: Rule out infection

  • ESR, CRP (if elevated → aspirate)
  • Hip aspiration if any suspicion
  • MSIS criteria to classify as aseptic vs septic

Step 3: Assess symptoms and function

  • Pain severity and functional limitation
  • Impact on activities of daily living
  • Patient expectations and goals

Step 4: Determine treatment approach

  • Symptomatic + radiographic progression → Surgery
  • Asymptomatic + early changes → Observation with serial X-rays
  • Minimal symptoms + stable → Conservative management

This systematic assessment guides appropriate management decisions for each patient.

Indications for non-operative management:

  • Minimal symptoms despite radiographic changes
  • Medical comorbidities prohibit surgery
  • Patient preference to delay surgery
  • Stable appearance on serial X-rays

Conservative measures:

  • Activity modification: Avoid high-impact activities
  • Weight optimization: Reduce joint forces
  • Analgesia: NSAIDs, paracetamol (avoid opioids long-term)
  • Walking aids: Cane in contralateral hand
  • Physiotherapy: Maintain muscle strength, gait training

Monitoring:

  • Serial radiographs (every 6-12 months)
  • Watch for progression of osteolysis
  • Document increasing migration
  • Reassess symptoms regularly

Indications to proceed to surgery:

  • Progressive pain interfering with function
  • Increasing migration (more than 5mm in 2 years)
  • Expanding osteolysis
  • Patient ready and medically optimized

Don't Wait Too Long

Delaying surgery until massive bone loss makes revision much more difficult. Paprosky Type IIIB acetabular or Type IV femoral defects require complex reconstruction. Consider surgery before bone stock critically depleted.

Pre-revision planning:

1. Infection ruled out:

  • Normal ESR/CRP OR negative aspiration
  • If any doubt, treat as infected (2-stage)

2. CT scan for bone loss assessment:

  • Paprosky classification (acetabulum and femur)
  • Plan reconstruction strategy
  • Identify pelvic discontinuity
  • Template for implant sizing

3. Implant removal plan:

  • Identify implant manufacturer and type
  • Plan extraction tools needed
  • Anticipate difficulty (well-fixed vs loose)
  • Have trephines, saws, ultrasonic tools available

4. Reconstruction strategy:

Acetabular options (based on Paprosky):

  • Type I-IIA: Hemispheric cup with screws
  • Type IIB-IIC: Jumbo cup, cluster screws
  • Type IIIA: High hip center, augments, or trabecular metal
  • Type IIIB: Cup-cage construct, custom triflange

Femoral options (based on Paprosky):

  • Type I-II: Cemented or proximally coated stem
  • Type IIIA: Extensively coated (diaphyseal fit)
  • Type IIIB: Long extensively coated, impaction grafting
  • Type IV: Modular tumor prosthesis, allograft-prosthesis composite

5. Bone graft planning:

  • Morselized graft for cavitary defects
  • Structural graft for segmental defects
  • Allograft vs autograft considerations

6. Blood management:

  • Type and cross-match (may need 2-4 units)
  • Cell saver intraoperatively
  • Tranexamic acid (reduce blood loss)

Comprehensive preoperative planning ensures all necessary equipment and resources are available for successful revision surgery.

Surgical approach:

  • Usually previous approach (if possible)
  • Posterior approach most common
  • Direct anterior if prior anterior
  • Extensile approaches if needed (trochanteric osteotomy)

Key steps:

1. Exposure:

  • Identify and protect neurovascular structures
  • Complete capsulectomy
  • Identify and remove previous hardware

2. Component removal:

  • Remove femoral head (if modular, disassociate)
  • Extract acetabular liner/component
  • Remove femoral stem
  • Remove all cement (if cemented)
  • Remove all membranes and debris

3. Acetabular reconstruction:

  • Ream to bleeding bone
  • Assess bone defects (Paprosky)
  • Reconstruct defects (grafts, augments, cages)
  • Implant revision cup
  • Achieve stability (screws, multihole fixation)

4. Femoral reconstruction:

  • Remove all cement, membranes
  • Ream or broach to stable fit
  • Address defects (bone graft, mesh)
  • Implant revision stem
  • Achieve axial and rotational stability

5. Closure and stability:

  • Trial reduction
  • Check leg length, offset
  • Assess stability through ROM
  • Repair capsule and soft tissues
  • Multilayer closure

These steps ensure systematic removal of failed components and stable reconstruction with new implants.

Surgical Technique - Revision for Aseptic Loosening

Surgical Approach Selection

Posterior approach (most common):

  • Good exposure to acetabulum and femur
  • Extensile if needed (trochanteric slide/osteotomy)
  • Familiar to most surgeons
  • Risk: Dislocation (especially if prior posterior approach)

Direct anterior approach:

  • If prior anterior primary
  • Good acetabular exposure
  • Difficult femoral exposure for revision
  • Limited extensile options

Lateral approach:

  • Less common for revisions
  • Risk to abductors
  • Transtrochanteric extension possible

Extended trochanteric osteotomy (ETO):

  • For difficult femoral extraction
  • Well-fixed uncemented stems
  • Cement column removal
  • Allows distal access to femur
  • Must repair and protect postoperatively

Key principles:

  • Adequate exposure is critical
  • Protect neurovascular structures
  • Plan extensile approach if needed
  • Don't fight through small exposure

Extended approaches allow safer component removal and better access for reconstruction.

Component Extraction Techniques

Acetabular component removal:

If loose:

  • Lever out with curved osteotomes
  • Remove screws first if accessible
  • Protect medial wall during extraction

If well-fixed:

  • Use flexible osteotomes around rim
  • Morselized bone graft removal
  • High-speed burr to thin shell
  • Ultrasonic tools for cement

Liner removal:

  • Extract liner first (if modular)
  • Use liner extraction tools
  • Protect shell if retaining

Femoral component removal:

If loose:

  • Slap hammer extraction
  • Protective boot to prevent fracture

If well-fixed (uncemented):

  • Extended trochanteric osteotomy (ETO)
  • Flexible osteotomes along stem
  • Gigli saw around stem
  • High-speed burr at cement interface

Cement removal:

  • Hand instruments first (osteotomes, curettes)
  • High-speed burr carefully
  • Ultrasonic cement removal
  • Trephines for distal cement plugs
  • Intraoperative X-ray to confirm complete removal

Prevent Fracture

Femoral fracture during removal is a major complication. Use extended trochanteric osteotomy for well-fixed stems or difficult cement. Controlled osteotomy is better than uncontrolled fracture.

Acetabular Reconstruction

Step 1: Prepare bone bed

  • Remove all membrane and granulation tissue
  • Ream to bleeding bone (may need to upsize cup)
  • Achieve hemispherical cavity
  • Assess bone defects (Paprosky classification)

Step 2: Manage bone defects

Cavitary defects (contained):

  • Morselized bone graft
  • Impaction technique
  • Use mesh if large

Segmental defects (uncontained):

  • Structural allograft
  • Metal augments (tantalum, titanium)
  • Custom triflange (massive defects)
  • Cup-cage construct (pelvic discontinuity)

Step 3: Cup implantation

  • Size for adequate contact (may need jumbo cup)
  • Press-fit fixation
  • Supplemental screw fixation (cluster holes)
  • Achieve 40-45 degrees inclination, 15-20 degrees anteversion

Step 4: Liner selection

  • Highly cross-linked polyethylene
  • Constrained liner if instability concern
  • Dual-mobility if recurrent dislocation

Achieving stable acetabular fixation requires addressing bone defects and achieving adequate surface contact. Proper liner selection balances wear resistance with stability requirements.

Femoral Reconstruction

Step 1: Prepare femoral canal

  • Remove all cement, membrane, debris
  • Broach or ream to stable fit
  • Identify level of stable bone contact

Step 2: Determine fixation strategy

Proximal fixation (Paprosky I-II):

  • Cemented stem (if good bone stock)
  • Modular stems (adjust offset, length)
  • Metaphyseal engaging stems

Diaphyseal fixation (Paprosky IIIA-IIIB):

  • Extensively coated cylindrical stems
  • Achieve 4-6cm diaphyseal contact
  • Scratch fit (tight distal fit)
  • Proximally modular if needed

Massive defects (Paprosky IV):

  • Impaction grafting (mesh and morselized graft)
  • Allograft-prosthesis composite
  • Modular tumor prosthesis

Step 3: Implant stem

  • Press-fit for uncemented (scratch fit distally)
  • Cement technique for cemented (restrict cement to supported bone)
  • Achieve axial and rotational stability

Step 4: Reconstruct trochanter (if ETO):

  • Cerclage wires or cables (2-3)
  • May use trochanteric grip or plates
  • Protected weight-bearing for 6 weeks

Femoral reconstruction aims for stable fixation, restoration of offset, and appropriate leg length.

Complications of Revision THA

Complications of Revision for Aseptic Loosening

ComplicationIncidencePrevention/Management
Dislocation5-15% (higher than primary)Restore offset, tension; constrained liner if needed
Intraoperative fracture5-10%Careful extraction; ETO for well-fixed stems
Periprosthetic fracture (postop)2-5%Protected weight-bearing; adequate fixation
Nerve injury1-3%Careful retraction; document preop exam
Infection2-5%Antibiotic prophylaxis; minimize operative time
Leg length discrepancyCommonTemplating; intraoperative measurement
Re-revision10-15% at 10 yearsAddress bone loss adequately; stable fixation
Thromboembolic disease1-2%Chemical and mechanical prophylaxis

Dislocation:

  • Higher risk than primary THA (abductor damage, soft tissue laxity)
  • Restore offset and leg length
  • Consider constrained liner or dual-mobility
  • Posterior repair if posterior approach

Intraoperative fracture:

  • Femoral fractures during stem removal (most common)
  • Treat with cerclage cables and/or revision to longer stem
  • Acetabular fractures (medial wall blow-out)
  • May need cage or column plating

Nerve injury:

  • Sciatic nerve most at risk (posterior approach, retraction)
  • Femoral nerve (anterior approach)
  • Document preoperative exam
  • Avoid excessive retraction and leg lengthening

Infection:

  • Higher risk in revision than primary
  • Meticulous debridement
  • Antibiotic prophylaxis
  • Consider vancomycin powder locally (controversial)

Dislocation Risk

Dislocation rates are higher after revision (5-15%) than primary (1-3%). Contributing factors: soft tissue damage, abductor insufficiency, poor bone stock affecting component position. Consider dual-mobility bearings or constrained liners in high-risk patients.

Postoperative Care and Rehabilitation

Immediate postoperative care:

Day 0-2
  • ICU/HDU if complex or prolonged case
  • DVT prophylaxis (chemical and mechanical)
  • Pain management (multimodal, avoid excessive opioids)
  • Monitor hemoglobin (transfuse if needed)
  • Foley catheter typically removed day 1
  • Early mobilization to chair
Day 2-5
  • Physiotherapy with walking frame
  • Partial weight-bearing (if uncemented femur)
  • Toe-touch weight-bearing (if ETO)
  • Hip precautions (if posterior approach)
  • Wound inspection
  • Progress to crutches or walker
Week 1-6
  • Progressive weight-bearing (if stable fixation)
  • Continue hip precautions for 6-12 weeks
  • Outpatient physiotherapy
  • Wound check at 2 weeks (remove sutures/staples)
  • First follow-up X-rays at 6 weeks
Week 6-12
  • Advance to full weight-bearing (if healing well)
  • Wean from walking aids
  • ETO protected until union (usually 12 weeks)
  • Progressive strengthening exercises
  • Monitor for complications
3-12 months
  • Return to normal activities gradually
  • Avoid high-impact sports indefinitely
  • Serial X-rays to monitor fixation (6 weeks, 3 months, 1 year)
  • Long-term follow-up annually

Weight-bearing restrictions:

  • Uncemented acetabulum: Partial weight-bearing for 6 weeks
  • Extensively coated femoral stem: May allow immediate weight-bearing
  • Extended trochanteric osteotomy: Toe-touch for 6 weeks, partial for 6-12 weeks
  • Bone grafting: Protected weight-bearing until graft incorporation

Hip precautions (if posterior approach):

  • No hip flexion more than 90 degrees
  • No adduction past midline
  • No internal rotation
  • Duration: 6-12 weeks (surgeon preference)

Monitoring for complications:

  • Wound infection signs (erythema, drainage)
  • DVT/PE symptoms (leg swelling, chest pain)
  • Neurovascular status
  • Pain out of proportion (compartment syndrome rare)

Long-term follow-up:

  • Radiographs: 6 weeks, 3 months, 1 year, then annually
  • Monitor for loosening, wear, osteolysis
  • Document stable fixation (osseointegration)
  • Check for heterotopic ossification

Outcomes and Prognosis

Revision THA outcomes:

Modern techniques and implants have improved revision THA outcomes substantially.

Survivorship (freedom from re-revision):

  • 10-year survivorship: 80-90% (modern series)
  • 15-year survivorship: 70-80%
  • Worse outcomes with severe bone loss (Paprosky IIIB/IV)

Factors affecting outcomes:

Patient factors:

  • Age (younger patients higher revision risk)
  • Activity level
  • BMI (obesity increases failure risk)
  • Bone quality

Surgical factors:

  • Severity of bone loss (Paprosky grade)
  • Surgeon experience with revisions
  • Achieving stable fixation
  • Managing soft tissue/abductor integrity

Implant factors:

  • Extensively coated stems (better outcomes than cemented in Paprosky III)
  • Tantalum augments/cups (good outcomes in deficient acetabulum)
  • Constrained liners (higher dislocation rate but necessary in some)

Functional outcomes:

  • Most patients achieve pain relief
  • Functional scores improve (Harris Hip Score, WOMAC)
  • Return to low-impact activities
  • Avoid high-impact sports

Australian context (AOANJRR data):

  • Revision for aseptic loosening accounts for approximately 25-30% of all revisions
  • Uncemented femoral stems have lower re-revision rates than cemented (in Paprosky III)
  • Trabecular metal cups show good outcomes in deficient acetabulum
  • Dual-mobility bearings reduce dislocation in revision setting

Registry Data

AOANJRR shows that aseptic loosening revision rates have decreased with modern implants (HXLPE, improved surfaces). However, when loosening occurs, revision is complex and outcomes are inferior to primary THA. Prevention through optimal primary technique is key.

Evidence Base

Level II
📚 Swedish Hip Arthroplasty Register - Long-term Loosening Data
Key Findings:
  • Analysis of 159,000 primary THAs showed aseptic loosening rate decreased from 10% at 10 years (1979-1985) to under 2% (2000-2006) with improved polyethylene and surfaces. Highly cross-linked PE reduced wear by 80-90%.
Clinical Implication: Modern implants with HXLPE have dramatically reduced aseptic loosening rates. Use of HXLPE is standard of care in primary THA.
Source: Acta Orthop 2010

Level II
📚 AOANJRR - Australian Registry Revision Data
Key Findings:
  • Aseptic loosening accounts for 25% of all revisions. Uncemented stems in revision have lower re-revision rates than cemented (8.5% vs 11.2% at 10 years). Trabecular metal cups show good fixation in bone loss.
Clinical Implication: Australian data supports use of uncemented extensively coated stems in revision. Trabecular metal useful for acetabular defects.
Source: AOANJRR Annual Report 2023

Level IV
📚 Paprosky Classification - Validation Studies
Key Findings:
  • Paprosky classification reliably predicts revision complexity and outcomes. Type I-II have 90-95% success with standard cups. Type IIIB requires advanced reconstruction (augments, cages) with 75-80% success.
Clinical Implication: Paprosky classification guides surgical planning. Severe bone loss (IIIB/IV) requires specialized techniques and has worse outcomes.
Source: J Arthroplasty 1994; Multiple follow-up studies

Level III
📚 Particle Disease Mechanism - Osteolysis Studies
Key Findings:
  • Polyethylene particles 0.1-10 microns activate macrophages. RANKL/OPG imbalance drives osteoclastogenesis. Cytokine polymorphisms (TNF-α, IL-1) affect osteolysis susceptibility. Cross-linked PE reduces particle generation by 90%.
Clinical Implication: Particle disease is biologic process. HXLPE reduces particle load. Genetic factors may explain variable osteolysis rates.
Source: J Bone Joint Surg Am 1998 (Purdue group)

Level III
📚 MSIS Criteria for Periprosthetic Joint Infection
Key Findings:
  • Validated criteria for PJI diagnosis. Major criteria (sinus tract, positive cultures) have 100% specificity. Minor criteria scored: synovial WBC more than 3000 or PMN more than 80% highly predictive. Alpha-defensin has 97% sensitivity and specificity.
Clinical Implication: Use MSIS criteria to differentiate aseptic from septic loosening. Hip aspiration is critical when inflammatory markers elevated.
Source: J Arthroplasty 2011 (updated 2018)

Exam Viva Scenarios

Practice these scenarios to excel in your viva examination

VIVA SCENARIOStandard

Scenario 1: Presentation of Aseptic Loosening

EXAMINER

"A 68-year-old man presents with progressive groin pain 12 years after cemented THA. He had good function until 18 months ago when pain gradually worsened. X-rays show progressive lucent lines in DeLee/Charnley zones I and II around the acetabular component, measuring 3mm. Gruen zone 1 and 7 show 2mm lucent lines on the femoral side. ESR is 18, CRP is 6. How do you assess and manage this patient?"

EXCEPTIONAL ANSWER
This gentleman presents with a classic picture of **aseptic loosening** affecting both components 12 years after his primary THA. The key features are gradual onset of pain, progressive radiographic changes, and normal inflammatory markers. **Assessment and Diagnosis:** The diagnosis is supported by: (1) **Gradual progression** over 18 months, (2) **Progressive lucent lines** in multiple zones exceeding 2mm thickness, (3) **Time frame** consistent with aseptic loosening (10-15 years), (4) **Normal inflammatory markers** (ESR 18, CRP 6) making infection less likely. However, I must emphasize that **infection exclusion is mandatory**. Even with normal markers, before proceeding with single-stage revision, I would perform **hip aspiration** under fluoroscopic guidance. I would send fluid for: cell count with differential (looking for WBC less than 3000, PMN less than 80%), culture (hold 14 days), and alpha-defensin. This is standard practice before any revision surgery. **Radiographic Assessment:** I would obtain **serial X-rays** comparing to prior films to document progression. The acetabular lucency in zones I and II (superior and medial DeLee/Charnley zones) is concerning as these are weight-bearing areas. Femoral lucency in zones 1 and 7 (proximal medial and lateral) suggests calcar resorption and possible stress shielding. I would order a **CT scan** to: (1) Better define bone loss using Paprosky classification, (2) Identify osteolysis not visible on plain films, (3) Plan reconstruction strategy, (4) Template for implant sizing. **Management Decision:** Given **symptomatic loosening** with progressive pain and radiographic progression, this patient is a candidate for **revision THA**. Conservative management is not appropriate given the progression and functional impact. **Surgical Planning:** Assuming aspiration confirms aseptic loosening, I would plan **single-stage revision** of both components. My approach would be: (1) CT to assess bone loss, (2) Plan reconstruction based on Paprosky classification, (3) Have bone graft available, (4) Prepare for possible complex acetabular reconstruction if significant bone loss, (5) Extended trochanteric osteotomy kit available if femoral extraction difficult. The key principles are: exclude infection, assess bone loss, plan appropriate reconstruction, and counsel patient about outcomes (80-90% survivorship at 10 years but inferior to primary THA).
KEY POINTS TO SCORE
Classic presentation: gradual pain, progressive lucent lines, 10-15 years post-THA
Lucent lines more than 2mm in DeLee/Charnley zones I-II (acetabulum) concerning
Gruen zone 1 and 7 lucency suggests calcar resorption and stress shielding
Normal ESR/CRP makes infection less likely but NOT excluded
Must perform hip aspiration before revision to rule out infection
Aspiration: send cell count, culture, alpha-defensin
MSIS criteria to classify as aseptic vs septic
CT scan for bone loss assessment (Paprosky classification)
Single-stage revision appropriate if confirmed aseptic
Plan reconstruction based on bone loss severity
Counsel about outcomes (good but not as good as primary)
COMMON TRAPS
✗Assuming aseptic without aspiration
✗Not getting serial X-rays to document progression
✗Proceeding without CT scan for surgical planning
✗Not counseling about inferior outcomes vs primary THA
✗Not checking for infection despite normal ESR/CRP
LIKELY FOLLOW-UPS
"The aspiration shows WBC 1500, PMN 40%, culture negative. The CT shows Paprosky Type IIA acetabular bone loss and Type II femoral bone loss. What is your surgical plan?"
"What are the MSIS criteria for periprosthetic joint infection?"
VIVA SCENARIOChallenging

Scenario 2: Differentiating Aseptic from Septic Loosening

EXAMINER

"A 72-year-old woman presents with 6 months of progressive hip pain, 8 years after uncemented THA. X-rays show lucent lines around the femoral stem in all Gruen zones. ESR is 45, CRP is 18. She has no fever or systemic symptoms. How do you proceed?"

EXCEPTIONAL ANSWER
This case presents a **diagnostic dilemma** - loosening with elevated inflammatory markers. While the patient has no systemic symptoms, the **elevated ESR (45) and CRP (18)** mean I **cannot assume this is aseptic loosening**. Infection must be definitively ruled out. **Critical Point - Infection Exclusion:** The elevated inflammatory markers (ESR more than 30, CRP more than 10) meet **MSIS minor criteria** thresholds for infection. While she lacks systemic symptoms, low-grade chronic infection can present exactly like this - progressive pain without fever. I would **absolutely perform hip aspiration** before any surgical planning. **Aspiration Technique:** I would perform aspiration under **fluoroscopic or ultrasound guidance**, using a lateral approach to avoid contamination. Critical steps: (1) Patient off antibiotics for 2 weeks prior, (2) Sterile technique, (3) Send for: **cell count with differential** (threshold: WBC more than 3000 or PMN more than 80% suggests infection), **culture** with extended incubation (hold 14 days for low-virulence organisms), **alpha-defensin** (high sensitivity and specificity for PJI). **Interpreting Results - MSIS Criteria:** I would apply the **Musculoskeletal Infection Society (MSIS) criteria**: **Major criteria (any one = infected):** 1. Sinus tract communicating with prosthesis 2. Two positive cultures of same organism **Minor criteria (scored):** - Elevated serum CRP (more than 10 mg/L) or D-dimer (more than 860 ng/mL) - Elevated serum ESR (more than 30 mm/hr) - Elevated synovial fluid WBC (more than 3000 cells/μL) - Elevated synovial PMN percentage (more than 80%) - Positive alpha-defensin - Positive leukocyte esterase - Positive histology (more than 5 PMNs per HPF in 5 HPF at 400x) - Positive purulence This patient already has elevated ESR and CRP (2 minor criteria). If aspiration shows elevated WBC or positive alpha-defensin, she meets criteria for infection despite no systemic symptoms. **Management Based on Aspiration:** **If aspiration suggests infection** (WBC more than 3000, PMN more than 80%, positive alpha-defensin, or positive culture): - Treat as **periprosthetic joint infection** - **Two-stage revision** is usual approach - Stage 1: Remove components, thorough debridement, antibiotic spacer - 6 weeks IV antibiotics - Stage 2: Reimplantation once infection cleared **If aspiration confirms aseptic** (WBC less than 3000, PMN less than 80%, negative cultures, negative alpha-defensin): - Proceed with **single-stage revision** as for aseptic loosening - Elevated markers may be due to particle disease (can cause mild inflammatory response) - Still counsel patient about aspiration results and decision-making The **key teaching point**: Never assume aseptic loosening when inflammatory markers are elevated. The consequences of treating an infected prosthesis as aseptic (single-stage revision) are disastrous - persistent infection, multiple failed revisions. When in doubt, aspirate.
KEY POINTS TO SCORE
Elevated ESR (45) and CRP (18) cannot be ignored
Must rule out infection despite lack of systemic symptoms
Low-grade chronic PJI presents exactly like aseptic loosening
Hip aspiration is mandatory with elevated inflammatory markers
MSIS criteria guide diagnosis: major and minor criteria
Major criteria: sinus tract OR two positive cultures
Minor criteria include: ESR more than 30, CRP more than 10, synovial WBC more than 3000, PMN more than 80%
Alpha-defensin has high sensitivity and specificity for PJI
If infected: two-stage revision (remove, antibiotic spacer, reimplant)
If aseptic confirmed: single-stage revision acceptable
Never assume aseptic when markers elevated - aspirate first
COMMON TRAPS
✗Assuming aseptic because no fever or systemic symptoms
✗Not performing aspiration with elevated markers
✗Not knowing MSIS criteria
✗Proceeding with single-stage revision without infection workup
✗Not counseling about difference in management if infected
LIKELY FOLLOW-UPS
"The aspiration shows WBC 4500 cells/μL with 85% PMNs. Culture is pending. What is your diagnosis and management?"
"What is the role of nuclear medicine imaging (bone scan, labeled WBC scan) in this scenario?"
VIVA SCENARIOCritical

Scenario 3: Severe Bone Loss - Paprosky IIIB

EXAMINER

"You are planning revision THA for aseptic loosening. The CT scan shows Paprosky Type IIIB acetabular bone loss with superior migration more than 4cm and destruction of the ischium and teardrop. There is also complete loss of the anterior and posterior columns. How do you manage this acetabular defect?"

EXCEPTIONAL ANSWER
This is a **severe acetabular deficiency** - Paprosky Type IIIB - which represents one of the most challenging scenarios in revision THA. The key features are: (1) Massive superior migration (more than 3cm defines Type III), (2) Loss of ischial bone (teardrop destruction), (3) **Column loss** (anterior and posterior), which may indicate **pelvic discontinuity**. **Assessment of Pelvic Discontinuity:** The mention of anterior and posterior column loss raises concern for **pelvic discontinuity** - a complete separation of superior and inferior hemipelvis through the acetabulum. I would carefully review the CT for: (1) **Fracture line** extending from acetabular roof through medial wall to obturator foramen, (2) **Differential motion** between superior and inferior segments on stress views, (3) **Gap** at the fracture site. Pelvic discontinuity changes the reconstruction approach - the pelvis must be stabilized before addressing the acetabular defect. **Reconstruction Strategy - Paprosky IIIB:** For this massive defect, a standard hemispheric cup will **not achieve adequate fixation**. My options in order of preference are: **Option 1: Cup-Cage Construct (My Preferred Approach)** This is becoming the standard for Paprosky IIIB with pelvic discontinuity: - **Jumbo hemispheric cup** (usually trabecular metal) placed at **high hip center** (where bone stock is better) - Cup fixed with multiple screws into remaining iliac bone - **Reconstruction cage** (Burch-Schneider or similar) spanning from ischium to ilium - Cage fixed with iliac screws and ischial flange - Cage protects the cup and transfers load across discontinuity - Morselized bone graft packed into defects The **cup provides biologic fixation** (osseointegration), while the **cage provides immediate mechanical stability**. This construct has shown good results in literature (70-80% survivorship at 10 years). **Option 2: Custom Triflange Implant** For massive bone loss where cup-cage may not work: - **CT-based custom triflange** with flanges fixed to ilium, ischium, and pubis - Immediate rigid fixation independent of bone quality - Requires detailed preoperative planning (4-6 weeks for manufacture) - Good for very severe defects or revision of failed cup-cage - Outcomes similar to cup-cage in experienced hands **Option 3: Allograft Reconstruction** Less commonly used now, but option: - Structural allograft (acetabular segment) to restore bone stock - Hemispheric cup cemented into allograft - High nonunion and resorption rates (30-40% failure at 10 years) - Generally reserved for younger patients where bone restoration desirable **Surgical Technique - Cup-Cage:** My approach would be: 1. **Extensive exposure** - may need trochanteric slide for superior access 2. **Remove all membrane and scar** - get to bleeding bone 3. **Assess discontinuity** - may need ORIF if mobile (plate from ilium to ischium) 4. **Ream high and medial** - where bone stock exists (high hip center) 5. **Implant jumbo trabecular metal cup** - maximize contact with remaining bone (often 66-70mm cup) 6. **Multiple screws** into ilium (superior and posterior) 7. **Morselized bone graft** to fill defects around cup 8. **Apply reconstruction cage** - span from ischium to ilium, fixed with screws 9. **Constrained liner** likely needed (superior migration increases dislocation risk) 10. **Test stability** before closure **Key Principles:** - **High hip center is acceptable** in this scenario - trying to restore native hip center with this bone loss leads to failure - Cup must have at least **50% host bone contact** for osseointegration - Cage provides **immediate stability** while cup osseointegrates (takes 3-6 months) - **Protected weight-bearing** for 6-12 weeks to allow osseointegration **Alternative if Pelvic Discontinuity:** If there is true discontinuity with mobility: 1. First **stabilize the pelvis** - may need posterior column plating 2. Then proceed with cup-cage as above 3. Cage bridges and compresses discontinuity **Postoperative Management:** - **Protected weight-bearing** (toe-touch to partial) for 6-12 weeks - Serial X-rays to monitor for cage or cup migration - High risk of complications (dislocation 10-15%, re-revision 20-25% at 10 years) - Counsel patient about expected outcomes and rehabilitation This is a complex reconstruction requiring subspecialty expertise, proper implants and instrumentation, and careful patient selection. Outcomes are inferior to standard revisions but can provide good pain relief and function when executed well.
KEY POINTS TO SCORE
Paprosky IIIB: superior migration more than 3cm, ischial/teardrop destruction
Check for pelvic discontinuity (fracture across acetabulum)
Standard hemispheric cup will not achieve adequate fixation
Cup-cage construct is current standard for IIIB defects
Jumbo trabecular metal cup at high hip center for biologic fixation
Reconstruction cage (Burch-Schneider type) for mechanical stability
Cage spans ischium to ilium, fixed with screws
Alternative: custom triflange implant (CT-based, 4-6 week lead time)
High hip center is acceptable - restoring native center leads to failure
Cup needs 50% host bone contact for osseointegration
Protected weight-bearing 6-12 weeks postoperatively
Outcomes: 70-80% survivorship at 10 years (worse than standard revision)
High complications: dislocation 10-15%, re-revision 20-25%
COMMON TRAPS
✗Trying to restore native hip center with this bone loss
✗Using standard hemispheric cup without cage support
✗Not recognizing pelvic discontinuity
✗Not stabilizing discontinuity before cup placement
✗Immediate full weight-bearing (needs protected weight-bearing)
✗Not counseling about inferior outcomes and high complications
✗Not having proper implants/instruments available
LIKELY FOLLOW-UPS
"What defines pelvic discontinuity and how would you diagnose it intraoperatively?"
"What are the results of cup-cage constructs from the literature?"
"Describe the Paprosky classification for acetabular bone loss."

MCQ Practice Points

Mechanism Question

Q: What is the primary mechanism by which polyethylene wear debris causes osteolysis in aseptic loosening?

A: Macrophage activation leading to cytokine release (TNF-α, IL-1, IL-6, RANKL). These cytokines recruit and activate osteoclasts, causing bone resorption. This is a biologic process (particle disease), not purely mechanical loosening.

Zone Question

Q: A patient has a 3mm lucent line in Gruen zone 1. What does this indicate?

A: Gruen zone 1 is the proximal medial (calcar) region. A 3mm lucent line (threshold is 2mm) indicates calcar resorption and suggests femoral component loosening or impending subsidence. This is concerning and warrants close follow-up or consideration of revision.

Infection Differentiation

Q: What is the threshold synovial fluid white blood cell count that suggests periprosthetic joint infection rather than aseptic loosening?

A: More than 3000 cells/μL OR more than 80% polymorphonuclear cells (PMNs). Either of these thresholds is a minor criterion in the MSIS criteria for PJI. Aseptic loosening typically has synovial WBC less than 3000 with less than 80% PMNs.

Classification Question

Q: A revision THA CT shows acetabular superior migration of 4cm with destruction of the ischium and teardrop. What Paprosky classification is this?

A: Paprosky Type IIIB. Type III is defined by superior migration more than 3cm. Type IIIB specifically has ischial and teardrop destruction (loss of Köhler's line), indicating severe bone loss. This requires complex reconstruction (cup-cage or triflange).

Treatment Question

Q: What is the primary advantage of highly cross-linked polyethylene (HXLPE) over conventional polyethylene in THA?

A: Reduced wear rate by 80-90% (from 0.1-0.2mm/year to under 0.05mm/year). This reduces particle generation, decreasing osteolysis and aseptic loosening rates. Registry data shows HXLPE has significantly improved long-term implant survivorship.

Radiology Question

Q: What radiographic finding is definitive for component loosening?

A: Migration of the component (change in position more than 5mm in 2 years) or component/cement fracture. Progressive lucent lines suggest loosening but are not definitive until migration occurs or lucency becomes circumferential (more than 2mm).

Australian Context

AOANJRR (Australian Orthopaedic Association National Joint Replacement Registry) Data:

The AOANJRR provides world-leading data on THA outcomes in Australia.

Key findings relevant to aseptic loosening:

Primary THA:

  • Aseptic loosening rate: Decreased from 10% at 10 years (1990s) to under 2% per year (2010s)
  • HXLPE impact: Introduction of highly cross-linked polyethylene in 2000s correlated with decreased loosening rates
  • Uncemented vs cemented: Similar loosening rates in modern implants (under 65 years: uncemented preferred; over 65: either acceptable)

Revision THA:

  • Aseptic loosening accounts for 25-30% of all revision indications
  • Uncemented stems in revision have lower re-revision rates than cemented (8.5% vs 11.2% at 10 years)
  • Trabecular metal cups show good fixation in acetabular bone loss scenarios
  • Dual-mobility bearings reduce dislocation risk in revision setting

Australian clinical practice:

The management of aseptic loosening in Australia follows a multidisciplinary approach with arthroplasty surgeons, infectious disease specialists (when infection suspected), and specialized anesthesia teams. Complex revisions are typically managed in major public hospitals with subspecialty expertise and access to advanced implants.

Registry participation through the AOANJRR is mandatory for all joint replacements in Australia. This world-leading registry provides comprehensive data showing that aseptic loosening rates have decreased significantly with modern highly cross-linked polyethylene. Uncemented stems are preferred in revision surgery based on registry evidence of superior outcomes, and trabecular metal components show good results for acetabular bone loss reconstruction.

Implant availability is excellent in Australia with both public and private sectors having access to advanced revision systems including modular stems, trabecular metal cups, reconstruction cages, and dual-mobility bearings. The choice of implants is increasingly guided by registry data demonstrating long-term outcomes.

Registry Importance

AOANJRR is the world's largest and most comprehensive joint replacement registry. For the Orthopaedic exam, be familiar with: (1) Aseptic loosening decreased with HXLPE, (2) Uncemented stems preferred in revision, (3) Trabecular metal useful for bone loss, (4) Dual-mobility reduces dislocation in revision.

ASEPTIC LOOSENING IN THA

High-Yield Exam Summary

DEFINITION AND MECHANISM

  • •Aseptic loosening = implant failure due to particle-induced osteolysis (NOT infection)
  • •Particle disease: PE wear → macrophage activation → cytokines (TNF-α, IL-1, RANKL) → osteoclasts → bone resorption
  • •Vicious cycle: loosening → micromotion → more particles → more osteolysis
  • •Most common late cause of THA revision (10-15 years post-primary)

RADIOGRAPHIC ZONES

  • •Gruen zones 1-7 (femur): Zone 1 (calcar), Zone 7 (lateral proximal)
  • •DeLee/Charnley I-III (acetabulum): Zone I (superior dome), Zone II (medial), Zone III (inferior)
  • •Lucent line more than 2mm = concerning for loosening
  • •Migration more than 5mm in 2 years = definite loosening
  • •Serial X-rays essential - progression is key finding

INFECTION EXCLUSION (CRITICAL)

  • •NEVER assume aseptic without ruling out infection
  • •Check ESR (threshold 30), CRP (threshold 10)
  • •If elevated markers: MUST perform hip aspiration
  • •Aspiration: WBC more than 3000 or PMN more than 80% suggests infection
  • •MSIS criteria: major (sinus, 2+ cultures) or minor (scored)
  • •Alpha-defensin: high sensitivity/specificity for PJI

PAPROSKY CLASSIFICATION

  • •Acetabular Type I: minimal bone loss (under 25%)
  • •Type IIA-IIB: 25-50% loss, migration under 3cm
  • •Type IIIA: migration more than 3cm, intact Köhler's line
  • •Type IIIB: migration more than 3cm + ischium/teardrop destruction
  • •Femoral Type I-II: metaphyseal loss, intact diaphysis
  • •Type IIIA-IIIB: diaphyseal involvement
  • •Type IV: non-supportive diaphysis

REVISION STRATEGY

  • •Rule out infection first (aspiration if any doubt)
  • •CT scan for bone loss assessment (Paprosky classification)
  • •Type I-IIA acetabulum: standard hemispheric cup
  • •Type IIB-IIIA: jumbo cup, augments, trabecular metal
  • •Type IIIB: cup-cage construct or custom triflange
  • •Femoral Type I-II: cemented or proximally coated
  • •Type IIIA-IIIB: extensively coated diaphyseal fit

KEY EXAM POINTS

  • •Aseptic loosening is biologic process (particle disease), not mechanical
  • •HXLPE reduced wear by 80-90% (modern standard)
  • •Always aspirate if ESR more than 30 or CRP more than 10 before revision
  • •Serial X-rays show progression (single film cannot diagnose)
  • •Outcomes: 80-90% survivorship at 10 years (worse than primary)
  • •AOANJRR shows uncemented stems better in revision than cemented
Quick Stats
Reading Time136 min
Related Topics

Adult Hip Dysplasia

Ankle Arthritis

Avascular Necrosis of the Hip

Dual Mobility Total Hip Arthroplasty